Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65789, first published .
Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study

Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study

Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study

Mengmeng Wang   1 * , MMSc ;   Lianxin Wang   1 * , MD ;   Fumei Liu   1 * , MMSc ;   Renbo Chen   1 * , MD ;   Zhifei Wang   1 , MD ;   Xin Cui   1 , MD ;   Yuanyuan Li   1 , MD ;   Yanming Xie   1 , MBBS

1 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China

*these authors contributed equally

Corresponding Author:

  • Yanming Xie, MBBS
  • Institute of Basic Research in Clinical Medicine
  • China Academy of Chinese Medical Sciences
  • No.16, Nanxiao Street
  • Dongzhimen, Dongcheng District
  • Beijing, 100700
  • China
  • Phone: 86 13911112416
  • Email: ktzu2018@163.com